• FirefoxInstall the new Firefox »
  •  Dow Down 0.39% Nasdaq Down 0.14%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    9.24 Up 0.31(3.47%) 12:43PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:8.93
    Open:8.93
    Bid:9.19 x 200
    Ask:9.23 x 100
    1y Target Est:11.22
    Beta:3.03
    Earnings Date:Mar 4 - Mar 6 (Est.)
    Day's Range:8.90 - 9.24
    52wk Range:5.22 - 13.64
    Volume:202,896
    Avg Vol (3m):366,320
    Market Cap:403.85M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXUp 3.47%403.85M
    BAXUp 0.19%37.74B
    CFNUp 0.20%12.31B
    HSPUp 0.19%15.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.97
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.95
    Quarterly EPS Est (Dec-14) :-0.30
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback